Healthcare provider profile · identity verified

Laura Norris, MD

Family Practice · CAMBRIDGE, VT · NPI 1174502082

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	385	103
Atorvastatin Calcium	Atorvastatin Calcium	378	109
Simvastatin	Simvastatin	251	68
Levothyroxine Sodium	Levothyroxine Sodium	242	69
Omeprazole	Omeprazole	220	68
Hydrochlorothiazide	Hydrochlorothiazide	209	60
Losartan Potassium	Losartan Potassium	206	61
Amlodipine Besylate	Amlodipine Besylate	138	36
Sertraline Hcl	Sertraline Hcl	135	33
Rosuvastatin Calcium	Rosuvastatin Calcium	120	33
Metformin Hcl Er	Metformin Hcl	119	38
Metoprolol Succinate	Metoprolol Succinate	106	27
Eliquis	Apixaban	95	29
Gabapentin	Gabapentin	90	27
Lorazepam	Lorazepam	89	20
Albuterol Sulfate Hfa	Albuterol Sulfate	86	37
Citalopram Hbr	Citalopram Hydrobromide	81	22
Fluoxetine Hcl	Fluoxetine Hcl	74	16
Venlafaxine Hcl Er	Venlafaxine Hcl	74	16
Meloxicam	Meloxicam	69	22
Furosemide	Furosemide	68	18
Bupropion Xl	Bupropion Hcl	66	13
Zolpidem Tartrate	Zolpidem Tartrate	64	21
Metformin Hcl	Metformin Hcl	62	19
Trazodone Hcl	Trazodone Hcl	60	17
Tamsulosin Hcl	Tamsulosin Hcl	56	22
Tramadol Hcl	Tramadol Hcl	56	17
Pantoprazole Sodium	Pantoprazole Sodium	54	19
Chlorthalidone	Chlorthalidone	51	14
Ozempic	Semaglutide	49	suppressed
Glipizide Er	Glipizide	48	13
Prednisone	Prednisone	45	22
Warfarin Sodium	Warfarin Sodium	45	12
Clonazepam	Clonazepam	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	11
Famotidine	Famotidine	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Spironolactone	Spironolactone	36	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Celecoxib	Celecoxib	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	17
Clopidogrel	Clopidogrel Bisulfate	33	11
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Atenolol	Atenolol	30	suppressed
Baclofen	Baclofen	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Finasteride	Finasteride	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Desmopressin Acetate	Desmopressin Acetate	24	suppressed
Cephalexin	Cephalexin	23	15
Montelukast Sodium	Montelukast Sodium	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Allopurinol	Allopurinol	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Estradiol	Estradiol	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Azithromycin	Azithromycin	16	13
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Topiramate	Topiramate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Digoxin	Digoxin	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error